Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Dyadic Charts. Click Here for more Dyadic Charts.](/p.php?pid=staticchart&s=A%5EDIL&p=8&t=15)
Dyadic International, Inc. (AMEX:DIL), a biotechnology
company engaged in the development, manufacture and sale of biological
products, announced today that its President and CEO, Mark Emalfarb,
will present at The Wall Street Analyst Forum, to be held on February
27th - March 2nd, 2006 at The Princeton Club on 15 West 43rd St. in
New York. The presentation will take place at 9:40 a.m. EST on
Wednesday, March 1, 2006, and will be webcast live. An archive of the
webcast will be available for 30 days. To access the live webcast or
archived presentation, please go to http://www.dyadic-group.com.
About Dyadic
Dyadic International, Inc., is engaged in the development,
manufacture and sale of proteins, enzymes and other bio-molecules, as
well as the licensing of its enabling proprietary technology to
collaborators for the discovery, development and manufacture of
biological products from genes. Dyadic markets its products and
services for applications in the textile, chemical, agricultural, pulp
& paper, pharmaceutical, biotechnology and other industries, using its
proprietary C1 Host Technology and C1 Expression and Screening Systems
for the discovery, development and production of biological products.
Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are
"forward-looking statements." These forward-looking statements involve
risks and uncertainties that could cause our actual results,
performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. For a discussion of these risks and
uncertainties, please see our filings from time to time with the
Securities and Exchange Commission, which are available free of charge
on the SEC's web site at http://www.sec.gov, including our Annual
Report on Form 10-KSB for the year ended December 31, 2004, and our
Quarterly Report on Form 10-QSB for the quarter ended September 30,
2005. Except as required by law, we expressly disclaim any intent or
obligation to update any forward-looking statements.